We are Sorry, This Page doesn't Exist
BookWatch: The risk Jeff Bezos takes with Amazon.com offers stock investors a valuable lesson
Seek and reward leaders who build, rebuild, and transform companies, writes Mark W. Johnson......»»
FISA reauthorization bill at risk of collapse after Trump push, creating headache for Speaker Johnson
FISA reauthorization bill at risk of collapse after Trump push, creating headache for Speaker Johnson.....»»
Investment Bank Piper Sandler Says Stocks Could See Turbulence If Bond Yields Rise: "I Don"t Think Equity Markets Are Going To Be Real Happy"
Johnson's comments come as investors brace for the latest Consumer Price Index (CPI) report. read more.....»»
Norway may drop AstraZeneca, J&J vaccines; EU will not take AstraZeneca one after June
Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson from its immunization program, due to a small risk of rare but serious side effects, a panel of health experts commissioned by .....»»
The Wall Street Journal: Elon Musk’s SpaceX is buying up a village in Texas Village. Homeowners are crying foul
In autumn 2019, Celia Johnson began resisting efforts by billionaire Elon Musk’s SpaceX to buy two modest houses she owns near the company’s rocket-launch facility......»»
Johnson & Johnson coronavirus vaccine should have warning labels about rare blood clots, but benefits outweigh risk, European agency says
The European Medicines Agency said these rare blood disorders should be considered as “very rare side effects of the vaccine.”The European Medicines Agency said these rare blood disorders should be considered as “very rare side effects of the vaccine.”.....»»
Stocks slip as traders digest Johnson & Johnson, IBM earnings, $30B Kansas City Southern deal
U.S. equity markets were lower Tuesday as investors assessed a mega-deal in the rail industry and sifted through a slew of earnings reports......»»
Dispatches from a Pandemic: The public’s expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%
‘It’s the same perceptual problem when we blindly drive to the airport texting, yet worry about the airplane.’.....»»
Netflix, Johnson & Johnson earnings top week ahead
Investors brace for a slew of earnings from Coca-Cola, Johnson & Johnson, United Airlines, Netflix, Chipotle, Intel, Snap, American Express and others in the coming week......»»
Dispatches from a Pandemic: The expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%
‘It’s the same perceptual problem when we blindly drive to the airport texting, yet worry about the airplane.’.....»»
Earnings Outlook: Here’s how the ‘pause’ on J&J’s COVID-19 shot may or may not affect the company’s earnings
To what degree will Johnson & Johnson’s COVID-19 vaccine manufacturing issues and the federal 'pause' over safety concerns weigh on investors' mind when the company reports earnings next week?.....»»
Dispatches from a Pandemic: Johnson & Johnson and AstraZeneca sagas illustrate strength of COVID-19 strategy: ‘It was a wise decision to spread the risk’
‘Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»
Dispatches from a Pandemic: What Johnson & Johnson and AstraZeneca’s problems reveal about the COVID-19 mass-vaccination campaign
‘It was a wise decision to spread the risk. Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»
Dispatches from a Pandemic: Johnson & Johnson and AstraZeneca problems are not unexpected — it would be more unusual to have NO vaccine problems
‘It was a wise decision to spread the risk. Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»
Dispatches from a Pandemic: ‘It was a wise decision to spread the risk’: Johnson & Johnson saga reveals vulnerabilities in COVID-19 vaccine strategy
“It’s still a race between the variants and the vaccine,” said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security......»»
Dispatches from a Pandemic: ‘It was a wise decision to spread the risk’: What Johnson & Johnson saga reveals about COVID-19 vaccination campaign
“It’s still a race between the variants and the vaccine,” said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security......»»
: Airline stocks stumble after vaccine rollout snag
U.S. airline stocks fall after Johnson & Johnson’s COVID-19 vaccine is halted with investors keeping an eye on upcoming airline earnings and the uptick in air-travel demand ahead of summer......»»
The US is pausing the Johnson & Johnson coronavirus vaccine rollout, citing the risk of rare blood clots
The US will stop distributing the Johnson & Johnson vaccine temporarily while federal agencies investigate a potential link to blood clots. A nurse loading a syringe with a dose of Johnson & Johnson's COVID-19 vacc.....»»
Mr. Cooper announces Kurt Johnson as Chief Risk and Compliance Officer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Dow soars 603 points amid risk-on rally as reopening stocks surge
Stocks were higher on Monday as the reopening of the US economy seemed within reach after Johnson and Johnson began distributing its one-dose vaccine. .....»»